Physician profile
Jozsef Piri
NPI 1457392185
$1,371.51
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $442 · 2021: $49.47.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $294.24 | 2019-2021 | |
| Novo Nordisk INC | $276.32 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $125.43 | 2019-2020 | |
| Amgen INC. | $118.04 | 2019-2020 | |
| Abbvie INC. | $105.62 | 2019-2021 | |
| Corcept Therapeutics | $73.31 | 2019-2020 | |
| Astellas Pharma US INC | $71.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.40 | 2019 | |
| Abbott Laboratories | $37.86 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $31.60 | 2019 | |
| Radius Health, INC. | $31.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.36 | 2019 | |
| Lifescan, INC. | $21.67 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.36 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.58 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.21 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jozsef Piri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.